Egypt’s Ibnsina Pharma records double earnings of 105% in Q2

Egypt-based pharmaceutical distribution company, Ibnsina Pharma’s (ISPH) profit doubled by 105.4 percent during the second quarter of the year to jump to 59.4 million pounds, compared to 28.9 million pounds for the same quarter of 2022.

The company’s sales rose in the second quarter to 7.8 billion pounds, compared with 4.9 billion pounds for the comparative quarter last year, according to statement on Sunday.